New York State Common Retirement Fund
TRAX

New York State Common Retirement Fund’s First Tracks Biotherapeutics TRAX Stock Holding History

New York State Common Retirement Fund’s Portfolio TRAX Stock Details TRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
+5,724
New +$107K ﹤0.01% 2606

Other funds holding TRAX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
FEG
Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

New York State Common Retirement Fund's TRAX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in First Tracks Biotherapeutics (TRAX) in Q2 2026: 5,724 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #2606 among its holdings.

20 funds tracked by Wall St. Rank hold TRAX as of Q2 2026.

  • New York State Common Retirement Fund held 5,724 shares of First Tracks Biotherapeutics worth $115K as of Q2 2026.
  • First Tracks Biotherapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • First Tracks Biotherapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2606 holding.
  • 20 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.